AOP Health Begins U.S. Rollout of Heart Rhythm Drug
WILMINGTON, DE — AOP Health US has begun commercial use of Rapiblyk, an intravenous heart rhythm treatment approved by the U.S. Food and Drug Administration last year, as hospitals seek …
AOP Health Begins U.S. Rollout of Heart Rhythm Drug Read More